UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1618) 1618
Book Chapter (17) 17
Dissertation (4) 4
Conference Proceeding (2) 2
Newspaper Article (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (568) 568
life sciences & biomedicine (554) 554
humans (448) 448
hematology (330) 330
middle aged (275) 275
oncology (264) 264
female (259) 259
male (259) 259
adult (249) 249
aged (247) 247
treatment outcome (185) 185
aged, 80 and over (169) 169
abridged index medicus (142) 142
leukemia (137) 137
hematology, oncology and palliative medicine (120) 120
antineoplastic agents - therapeutic use (112) 112
young adult (112) 112
prognosis (108) 108
adolescent (103) 103
protein kinase inhibitors - therapeutic use (103) 103
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (99) 99
chronic myeloid leukemia (95) 95
cancer (93) 93
hemic and lymphatic diseases (92) 92
antineoplastic combined chemotherapy protocols - therapeutic use (89) 89
care and treatment (87) 87
disease-free survival (81) 81
acute myeloid leukemia (79) 79
chemotherapy (76) 76
dasatinib (74) 74
pyrimidines - therapeutic use (66) 66
patients (64) 64
imatinib mesylate (63) 63
myelodysplastic syndromes - drug therapy (62) 62
leukemia, myeloid, acute - drug therapy (61) 61
survival analysis (58) 58
acute lymphoblastic leukemia (57) 57
retrospective studies (57) 57
follow-up studies (55) 55
myeloid leukemia (55) 55
survival rate (55) 55
analysis (54) 54
imatinib (54) 54
mutation (54) 54
research (54) 54
protein-tyrosine kinases - antagonists & inhibitors (52) 52
risk factors (51) 51
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (50) 50
transplantation (50) 50
benzamides (48) 48
remission induction (48) 48
tyrosine (47) 47
piperazines - therapeutic use (45) 45
fusion proteins, bcr-abl - genetics (44) 44
myelodysplastic syndromes (43) 43
recurrence (42) 42
survival (42) 42
leukemia, myelogenous, chronic, bcr-abl positive - genetics (41) 41
philadelphia chromosome (41) 41
protein kinase inhibitors - administration & dosage (40) 40
antineoplastic combined chemotherapy protocols - adverse effects (39) 39
myelodysplastic syndrome (39) 39
dosage and administration (38) 38
kaplan-meier estimate (38) 38
nilotinib (38) 38
antineoplastic agents - administration & dosage (37) 37
antineoplastic agents - adverse effects (37) 37
cytogenetics (37) 37
stem cells (36) 36
drug administration schedule (35) 35
drug resistance, neoplasm (35) 35
drug therapy (35) 35
remission (35) 35
stem cell transplantation (35) 35
azacitidine - analogs & derivatives (34) 34
protein kinase inhibitors - adverse effects (34) 34
cytarabine (33) 33
leukemia, myelogenous, chronic, bcr-abl positive - mortality (33) 33
tyrosine kinase inhibitors (33) 33
age factors (32) 32
clinical trials as topic (32) 32
myelodysplastic syndromes - pathology (32) 32
acute lymphatic leukemia (31) 31
clinical trials (31) 31
cytarabine - administration & dosage (31) 31
leukemia, myeloid, acute - mortality (31) 31
myelodysplastic syndromes - mortality (31) 31
protein-tyrosine kinase (31) 31
acute lymphocytic leukemia (30) 30
dose-response relationship, drug (30) 30
multivariate analysis (30) 30
clinical trials and observations (29) 29
leukemia, myeloid, chronic-phase - drug therapy (29) 29
pyrimidines - administration & dosage (29) 29
surgery (29) 29
bone marrow (28) 28
health aspects (28) 28
leukemia, myeloid, acute - genetics (28) 28
lymphatic leukemia (28) 28
patient outcomes (28) 28
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of hematology, ISSN 0361-8609, 03/2018, Volume 93, Issue 3, pp. 442 - 459
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 06/2011, Volume 29, Issue 18, pp. 2521 - 2527
Journal Article
American journal of hematology, ISSN 0361-8609, 05/2014, Volume 89, Issue 5, pp. 547 - 556
Disease overview: Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1–2 cases per 100,000 adults, and accounts for ∼15% of... 
Life Sciences & Biomedicine | Hematology | Science & Technology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Drug approval | Chronic myeloid leukemia | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 3, pp. 392 - 397
Purpose Although most patients with chronic myeloid leukemia (CML) in chronic phase respond well to front-line therapy with imatinib, some patients do not... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Young Adult | Pyrimidines - therapeutic use | Humans | Leukemia, Myeloid, Chronic-Phase - drug therapy | Middle Aged | Aged, 80 and over | Adult | Female | Male | Aged | Antineoplastic Agents - therapeutic use | Index Medicus | Hema7 | Original Reports | Hema23
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 3, pp. 398 - 404
Purpose Dasatinib is effective therapy for chronic myeloid leukemia (CML) after imatinib failure. In this study, we investigate the efficacy of dasatinib as... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Young Adult | Dasatinib | Pyrimidines - therapeutic use | Humans | Leukemia, Myeloid, Chronic-Phase - drug therapy | Middle Aged | Adolescent | Adult | Aged | Antineoplastic Agents - therapeutic use | Thiazoles - therapeutic use | Index Medicus | Hema7 | Original Reports
Journal Article
Journal Article